Viewing StudyNCT03861273



Ignite Creation Date: 2024-05-06 @ 12:51 PM
Last Modification Date: 2024-10-26 @ 1:05 PM
Study NCT ID: NCT03861273
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-05-03
First Post: 2019-03-01

Brief Title: A Study to Evaluate the Efficacy and Safety of Factor IX Gene Therapy With PF-06838435 in Adult Males With Moderately Severe to Severe Hemophilia B
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Hemophilia B
Keywords:
Name View
PF 06838435 View
Hemophilia View
Hemophilia B View
Factor IX View
FIX View
Gene Therapy View
Infusion View
rAAV Spark100 hFIX Padua View
rAAV Spark100-hFIX-R338L View
R338L View
BeneGene 2 View
Hematological Diseases View
Annualized bleeding rate ABR View